Wolverine Trading
GMED icon

Wolverine Trading’s Globus Medical GMED Stock Holding History

Wolverine Trading’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,500
Closed -$908K – 5812
2025
Q2 		$908K Sell
15,500
-16,100
-51% -$1.04M ﹤0.01% 2403
2025
Q1 		$2.29M Buy
31,600
+15,600
+98% +$1.29M ﹤0.01% 1510
2024
Q4 		$1.32M Buy
16,000
+700
+5% +$55.2K ﹤0.01% 2383
2024
Q3 		$1.08M Sell
15,300
-2,200
-13% -$155K ﹤0.01% 2274
2024
Q2 		$1.2M Buy
+17,500
New +$1.05M ﹤0.01% 2028
2023
Q4 		– Sell
-7,600
Closed -$377K – 4750
2023
Q3 		$377K Buy
+7,600
New +$425K ﹤0.01% 3064
2023
Q2 		– Sell
-6,900
Closed -$384K – 4496
2023
Q1 		$384K Buy
+6,900
New +$442K ﹤0.01% 2760
2022
Q1 		– Sell
-2,800
Closed -$203K – 5775
2021
Q4 		$203K Buy
+2,800
New +$203K ﹤0.01% 4689
2021
Q2 		– Sell
-26,700
Closed -$1.63M – 6260
2021
Q1 		$1.63M Buy
26,700
+20,100
+305% +$1.27M ﹤0.01% 2156
2020
Q4 		$428K Sell
6,600
-30,900
-82% -$1.78M ﹤0.01% 3348
2020
Q3 		$1.83M Sell
37,500
-10,800
-22% -$557K ﹤0.01% 1547
2020
Q2 		$2.29M Buy
+48,300
New +$2.33M 0.01% 1312
2020
Q1 		– Sell
-11,300
Closed -$664K – 4848
2019
Q4 		$664K Buy
+11,300
New +$613K ﹤0.01% 2809
2019
Q1 		– Sell
-14,900
Closed -$640K – 4790
2018
Q4 		$640K Buy
14,900
+3,600
+32% +$180K ﹤0.01% 2406
2018
Q3 		$641K Buy
11,300
+2,500
+28% +$132K ﹤0.01% 2811
2018
Q2 		$438K Hold
8,800
– – ﹤0.01% 3242
2018
Q1 		$438K Sell
8,800
-3,300
-27% -$155K ﹤0.01% 3242
2017
Q4 		$497K Buy
+12,100
New +$424K ﹤0.01% 3003
2017
Q3 		– Sell
-6,100
Closed -$204K – 4623
2017
Q2 		$204K Sell
6,100
-4,300
-41% -$135K ﹤0.01% 3572
2017
Q1 		$306K Buy
+10,400
New +$284K ﹤0.01% 2997

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Wolverine Trading's GMED Position: Q3 2025 in Review

Wolverine Trading opened a new position in Globus Medical (GMED) in Q3 2025: 9,743 shares worth $550K. The stake represents ﹤0.01% of the portfolio and ranks #3603 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in GMED as recently as Q1 2024.

Wolverine Trading first reported a position in GMED in Q4 2017 and has held it in 8 quarters since. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Wolverine Trading held 9,743 shares of Globus Medical worth $550K as of Q3 2025.
  • Globus Medical was a new Wolverine Trading position in Q3 2025.
  • Globus Medical made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3603 holding.
  • Wolverine Trading first reported a position in Globus Medical in Q4 2017 and has held it in 8 quarters since.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.